Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics, March 2014 (p30)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

871-920 of about 30 000 reports
MicroRNAs in Cancer Drug Pipeline Update 2014

MicroRNAs in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The hot entry of microRNA (miRNA) targeting drugs in oncology may come to revolutionize how we in the near future can launch a highly tumor-specific, multi-targeted attack with minimal toxicities eithe ...

  • Industries : Drug and Medication
Lung Cancer Drug Pipeline Update 2014

Lung Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D ...

  • Industries : Drug and Medication
Colorectal Cancer Drug Pathway Analyzer 2014

Colorectal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 375 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Angiogenesis in Oncology Drug Pipeline Update 2014

Angiogenesis in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 283 companies plus partners developing 333 angiogenesis drugs in 1516 developmental projects in cancer. In addition, there are 7 suspended drugs and the accumulated number of ceased drugs ...

  • Industries : Drug Discovery and Development
Lymphoma Drug Pipeline Update 2014

Lymphoma Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. There are today 248 companies plus partners developing 372 lymphoma drugs in 588 developmental projects in cancer. In ...

  • Industries : Pathology
Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2014

Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 10 companies plus partners developing 10 metabolic pathways targeting drugs in 22 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years ...

  • Industries : Drug and Medication
Lung Cancer Drug Pathway Analyzer 2014

Lung Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 487 targeted molecular therapies known to affect more than 254 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Melanoma Drug Pipeline Update 2014

Melanoma Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Melanoma comprises just 5% of all skin cancers but it is the most deadly. High unmet needs still persist for this tumor type and despite three decades of extensive R&D, five-year survival of advanced patients ...

  • Industries : Pathology
Fc Epsilon RI Signaling Pathway in Oncology Drug Pipeline Update 2014

Fc Epsilon RI Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Fc epsilon RI-mediated signaling pathways in mast cells are initiated by the interaction of antigen (Ag) with IgE bound to the extracellular domain of the alpha chain of Fc epsilon RI. The activation pathways ...

  • Industries : Drug Discovery and Development
ErbB Signaling Pathway in Cancer Drug Pipeline Update 2014

ErbB Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, ...

  • Industries : Drug and Medication
Prostate Cancer Drug Pathway Analyzer 2014

Prostate Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 386 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Peptides in Oncology: Drug Pathway Analyzer 2014

Peptides in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 188 peptide drugs known to affect more than 216 specific intracellular signaling pathways for the treatment ...

  • Industries : Drug Discovery and Development
Apoptosis in Oncology Drug Pipeline Update 2014

Apoptosis in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis ...

  • Industries : Drug Discovery and Development
Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2014

Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Cell-matrix adhesions play essential roles in important biological processes including cell motility, cell proliferation, cell differentiation, regulation of gene expression and cell survival. At the ...

  • Industries : Drug and Medication
Chemokine Signaling Pathway in Cancer Drug Pipeline Update 2014

Chemokine Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Inflammatory immune response requires the recruitment of leukocytes to the site of inflammation upon foreign insult. Chemokines are small chemoattractant peptides that provide directional cues for the ...

  • Industries : Drug and Medication
Leukemia Drug Pathway Analyzer 2014

Leukemia Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 379 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways ...

  • Industries : Pathology
Ovarian Cancer Drug Pipeline Update 2014

Ovarian Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for existing ...

  • Industries : Drug and Medication
FSH Signaling Pathway in Oncology Drug Pipeline Update 2014

FSH Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Follicle stimulating hormone (FSH) binds to FSH-receptor which is coupled to Gs protein that in turn activates cAMP dependent protein kinases (PKA) and thus triggers FSH signaling which continues furthe ...

  • Industries : Drug Discovery and Development
Gap Junctions in Oncology Drug Pipeline Update 2014

Gap Junctions in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Gap junctions contain intercellular channels that allow direct communication between the cytosolic compartments of adjacent cells. Each gap junction channel is formed by docking of two 'hemichannels', ...

  • Industries : Drug Discovery and Development
Hematological Cancers Drug Pathway Analyzer 2014

Hematological Cancers Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 672 targeted molecular therapies known to affect more than 256 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Nucleic Acid Therapies in Oncology: Drug Pathway Analyzer 2014

Nucleic Acid Therapies in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 285 nucleic acid drugs known to affect more than 223 specific intracellular signaling pathways for the treatment ...

  • Industries : Therapy
Brain Cancer Drug Pipeline Update 2014

Brain Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Despite the heavy investment made into brain cancer research, primary brain cancer, with glioblastoma multiforme being the most aggressive and most common form, remains one of the most deadly diseases ...

  • Industries : Drug and Medication
Pancreatic Cancer Drug Pipeline Update 2014

Pancreatic Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 270 companies plus partners developing 318 drugs targeting pancreatic cancer in development. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last ...

  • Industries : Drug and Medication
IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2014

IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The IL-2 signaling pathway activates the Ras/MAPK, JAK/Stat and PI 3-kinase/Akt signaling modules. There are today 239 companies plus partners developing 360 IL-2 pathway targeting drugs in 1260 developmental ...

  • Industries : Drug Discovery and Development
TSH Signaling Pathway in Oncology Drug Pipeline Update 2014

TSH Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Human thyroid stimulating hormone (TSH) exerts its action through various signaling cascades such as cAMP cascade and the phospholipase C beta-mediated inositol phosphate generation. Further, it will give ...

  • Industries : Drug Discovery and Development
GnRH Signaling Pathway in Oncology Drug Pipeline Update 2014

GnRH Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus acts upon its receptor in the anterior pituitary to regulate the production and release of the gonadotropins, LH and FSH. There are ...

  • Industries : Drug Discovery and Development
Transcriptional Misregulation in Cancer Drug Pipeline Update 2014

Transcriptional Misregulation in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 219 companies plus partners developing 290 transcriptional misregulation targeting drugs in 1153 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated ...

  • Industries : Drug and Medication
Proteins in Oncology: Drug Pathway Analyzer 2014

Proteins in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 353 protein drugs known to affect more than 202 specific intracellular signaling pathways for the treatment ...

  • Industries : Drug Discovery and Development
Breast Cancer Drug Pipeline Update 2014

Breast Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic setting, ...

  • Industries : Drug and Medication
Peptides in Oncology Drug Pipeline Update 2014

Peptides in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 236 companies plus partners developing 226 peptide drugs in 579 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ove ...

  • Industries : Drug Discovery and Development

» View Public Reports

About 41 000 reports

Global Clinical Trial : Innovation and Technology Trends

  • Industry report
  • April 2014
  • 16 pages

... Complexities, and so on). Within the cro market, the largest segment was that of drug discovery. Based on various analyses, the report also anticipates that the market for clinical data management services ...


» Read our Company Profiles

About 600 Companies

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.